Tetrazepam
MUSCULO-SKELETAL SYSTEM
Also known as: myolastan
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Tetrazepam is a drug catalogued in DrugCentral.
- ATC code: M03BX07 (Other centrally acting agents).
- Molecular formula: C16H17ClN2O; molecular weight 288.78 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M03BX07 | MUSCULO-SKELETAL SYSTEM › MUSCLE RELAXANTS › MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS › Other centrally acting agents |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Logorrhoea | 98.0 |
| Transposition of the great vessels | 93.8 |
| Toxicity to various agents | 90.9 |
| Cross sensitivity reaction | 86.4 |
| Dermatitis contact | 81.5 |
| Vestibular disorder | 65.4 |
| Eczema eyelids | 58.4 |
| Skin test positive | 55.8 |
| Occupational exposure to product | 55.0 |
| Disturbance in attention | 53.5 |
| Ventricular septal defect | 52.2 |
| Agoraphobia | 48.0 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Tetrazepam is on its molecule page.
| Molecular formula | C16H17ClN2O |
|---|---|
| Molecular weight | 288.78 g/mol |
| CAS number | 10379-14-3 |
| InChIKey | IQWYAQCHYZHJOS-UHFFFAOYSA-N |
| PubChem CID | 25215 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Tetrazepam?
Tetrazepam has the molecular formula C16H17ClN2O and a molecular weight of 288.78 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2614 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2105527 — compound record and bioactivity
- PubChem CID 25215 — chemical identifiers
- DrugBank DB13324 — drug record
- FDA UNII FO92091VP8 — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.